MXD4
Max dimerization protein 4
Also known as: bHLHc12, MAD4, MAD4_HUMAN, MST149, MSTP149
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14582
- Gene
- MXD4
- Ensembl
- ENSG00000123933
- Chromosome
- 4
- Canonical length
- 209 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene is a member of the MAD gene family . The MAD genes encode basic helix-loop-helix-leucine zipper proteins that heterodimerize with MAX protein, forming a transcriptional repression complex. The MAD proteins compete for MAX binding with MYC, which heterodimerizes with MAX forming a transcriptional activation complex. Studies in rodents suggest that the MAD genes are tumor suppressors and contribute to the regulation of cell growth in differentiating tissues. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
209 residues, UniProt reviewed canonical sequence.
>Q14582|MXD4
1 MELNSLLILL EAAEYLERRD REAEHGYASV LPFDGDFARE KTKAAGLVRK APNNRSSHNE
61 LEKHRRAKLR LYLEQLKQLV PLGPDSTRHT TLSLLKRAKV HIKKLEEQDR RALSIKEQLQ
121 QEHRFLKRRL EQLSVQSVER VRTDSTGSAV STDDSEQEVD IEGMEFGPGE LDSVGSSSDA
181 DDHYSLQSGT GGDSGFGPHC RRLGRPALSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MXD4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 123 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 123 nTPM
- pituitary gland: 66 nTPM
- spleen: 58 nTPM
- blood vessel: 49 nTPM
- adrenal gland: 43 nTPM
- cerebral cortex: 41 nTPM
Single-cell type
- breast lactating cells: 128 nCPM
- kupffer cells: 119 nCPM
- pdcs: 117 nCPM
- lactotrophs: 96 nCPM
- epididymal principal cells: 96 nCPM
- microglia: 94 nCPM
Immune cell
- basophil: 7.2 nTPM
- plasmacytoid DC: 7.2 nTPM
- T-reg: 4 nTPM
- eosinophil: 3.4 nTPM
- gdT-cell: 3.4 nTPM
- memory CD8 T-cell: 3.3 nTPM
Brain region
- cerebellum: 86 nTPM
- amygdala: 48 nTPM
- cerebral cortex: 47 nTPM
- thalamus: 44 nTPM
- midbrain: 42 nTPM
- medulla oblongata: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.78
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- protein dimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MXD4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MXD4 as an antibody target. Whether an autoantibody or antibody against MXD4 could matter depends on whether native MXD4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MXD4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MXD4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...